Patents Assigned to TRI-INOV
  • Use of zinc N-acetyltaurinate
    Patent number: 9029419
    Abstract: The subject matter of the present invention is Zn N-acetyltaurinate of formula: [CH3—CO—NH—CH2—CH2—SO3]2?Zn2+ for preventing and/or treating diseases with lipofuscin accumulation due in particular to aging or to oxidative stress, and for preparing a medicament that is of use in treating these diseases. Use: treatment of diseases related to aging or to oxidative stress, in particular age-related macular degeneration and diabetic retinopathy.
    Type: Grant
    Filed: February 25, 2009
    Date of Patent: May 12, 2015
    Assignee: TRI-INOV
    Inventor: Jean Durlach
  • ZINC N-ACETYL TAURINATE FOR THE TREATMENT OF PROSTATE CANCER
    Publication number: 20140051754
    Abstract: The present invention relates to Zn N-acetyl taurinate of formula (I): [CH3—CO—NH—CH2—CH2—SO3]?2Zn2+ for the use thereof for treating prostate cancer
    Type: Application
    Filed: April 5, 2012
    Publication date: February 20, 2014
    Applicant: TRI-INOV
    Inventor: Jean Pierre Durlach
  • NOVEL USE OF ZINC N-ACETYLTAURINATE
    Publication number: 20110003891
    Abstract: The subject matter of the present invention is Zn N-acetyltaurinate of formula: [CH3—CO—NH—CH2—CH2—SO3]2?Zn2+ for preventing and/or treating diseases with lipofuscin accumulation due in particular to aging or to oxidative stress, and for preparing a medicament that is of use in treating these diseases. Use: treatment of diseases related to aging or to oxidative stress, in particular age-related macular degeneration and diabetic retinopathy.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 6, 2011
    Applicant: TRI-INOV
    Inventor: Jean Durlach